Strength
2 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237015901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
REPAGLINIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203820On Market Since
1/22/2014
Pharmacological Classes
Glinide
Potassium Channel Antagonists
Related Drugs
Same classification
NATEGLINIDE 60 MG TABLET
Generic
16571075809•Rising Pharma Holdings Inc.
$0.1974
per EA
NATEGLINIDE 60 MG TABLET
Generic
55111032890•Dr. Reddy's Laboratories Inc.
$0.1974
per EA
NATEGLINIDE 60 MG TABLET
Generic
60687067321•American Health Packaging
$0.1974
per EA
NATEGLINIDE 60 MG TABLET
Generic
64380016702•Strides Pharma Inc.
$0.1974
per EA
NATEGLINIDE 60 MG TABLET
Generic
68382072116•Zydus Pharmaceuticals (USA) Inc.
$0.1974
per EA
NATEGLINIDE 60 MG TABLET
Generic
72241000204•Modavar Pharmaceuticals LLC
$0.1974
per EA
NATEGLINIDE 60 MG TABLET
Generic
72241000205•Modavar Pharmaceuticals LLC
$0.1974
per EA
NATEGLINIDE 60 MG TABLET
Generic
75834020501•Nivagen Pharmaceuticals Inc.
$0.1974
per EA
NATEGLINIDE 120 MG TABLET
Generic
16571075909•Rising Pharma Holdings Inc.
$0.2510
per EA
NATEGLINIDE 120 MG TABLET
Generic
55111032990•Dr. Reddy's Laboratories Inc.
$0.2510
per EA